These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28231439)

  • 1. The rights of drug treatment patients: Experience of addiction treatment in Poland from a human rights perspective.
    Klingemann J
    Int J Drug Policy; 2017 May; 43():67-73. PubMed ID: 28231439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "In their perception we are addicts": social vulnerabilities and sources of support for men released from drug treatment centers in Vietnam.
    Tomori C; Go VF; Tuan le N; Huong NM; Binh NT; Zelaya CE; Celentano DD; Dat do T; Quan VM
    Int J Drug Policy; 2014 Sep; 25(5):897-904. PubMed ID: 24857185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.
    Treloar C; Rance J; Grebely J; Dore GJ
    Drug Alcohol Depend; 2013 Dec; 133(2):529-34. PubMed ID: 23932843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is low threshold methadone maintenance treatment?
    Strike C; Millson M; Hopkins S; Smith C
    Int J Drug Policy; 2013 Nov; 24(6):e51-6. PubMed ID: 23743178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative study of how Danish drug consumption rooms influence health and well-being among people who use drugs.
    Kappel N; Toth E; Tegner J; Lauridsen S
    Harm Reduct J; 2016 Jun; 13(1):20. PubMed ID: 27306441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
    Treloar C; Rance J;
    Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stigma and its determinants among male drug dependents receiving methadone maintenance treatment.
    Etesam F; Assarian F; Hosseini H; Ghoreishi FS
    Arch Iran Med; 2014 Feb; 17(2):108-14. PubMed ID: 24527971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring stakeholder perceptions of facilitators and barriers to accessing methadone maintenance clinics in Yunnan Province, China.
    Philbin MM; Zhang F
    AIDS Care; 2010 May; 22(5):623-9. PubMed ID: 20229375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Harm reduction interventions in drug users: current situation and recommendations].
    Bosque-Prous M; Brugal MT
    Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.
    Treloar C; Rance J; Yates K; Mao L
    Int J Drug Policy; 2016 Jan; 27():138-45. PubMed ID: 26394538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness to the hospital patient needs in Poland.
    Gromulska L; Supranowicz P; Wysocki MJ
    Rocz Panstw Zakl Hig; 2014; 65(2):155-64. PubMed ID: 25272583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-help group for drug-addicted clients. Assisted implementation in outpatient treatment.
    Félix-Ortiz de la Garza M; Sorensen JL
    J Subst Abuse Treat; 1995; 12(4):259-68. PubMed ID: 8830153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
    Ashford RD; Curtis B; Brown AM
    Harm Reduct J; 2018 Oct; 15(1):52. PubMed ID: 30348170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selections of reality: applying Burke's dramatism to a harm reduction program.
    Järvinen M; Miller G
    Int J Drug Policy; 2014 Sep; 25(5):879-87. PubMed ID: 24702965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stigmatizing harm reduction through language: a case study into the use of "addict" and opposition to supervised injection sites in Canada.
    Cortina SC
    J Addict Nurs; 2013; 24(2):102-7. PubMed ID: 24621488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on Vickerman et al. (2012): Reducing hepatitis C virus among injection drug users through harm reduction programs.
    Smith-Spangler CM; Asch SM
    Addiction; 2012 Nov; 107(11):1996-7. PubMed ID: 23039752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.